FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309463279> ?p ?o ?g. }

• W4309463279 endingPage "724" @default.
• W4309463279 startingPage "718" @default.
• W4309463279 abstract "Objectives: The primary objective of the study was to compare the number of patients with febrile seizure recurrence within 1 year of presenting to our institute, among patients who received and didn’t receive oral iron supplementation. Materials and Methods: This prospective intervention study with historical controls was conducted to compare the number of patients with febrile seizure recurrence within 1 year, among patients who received and did not receive oral iron supplementation. The intervention group additionally received prophylactic iron supplementation of 20 mg biweekly for 1 year. Results: A total of 53 patients each were enrolled in both the groups, with comparable baseline characteristics. Although there was a trend toward a lower rate of recurrence of febrile seizures in the interventional group, as compared to the control group, it did not reach the point of statistical significance ( P = 0.35). Both in the worst-case scenario and best-case scenario, there was a trend toward less risk of recurrence of febrile seizure in the intervention group, but it did not reach the point of statistical significance ( P = 0.43 and 0.52). For the original scenario, worst-case scenario, and best-case scenario, the absolute risk reduction was 6.5%, 7%, and 6%, respectively, with corresponding number needed to treat (NNT) being 15, 14, and 16, respectively. The trend for absolute risk reduction was more pronounced in those with complex febrile seizures with an NNT of 6.5, but it still did not reach the point of statistical significance ( P = 0.16). Moderate/severe IDA was also found to be an independent risk factor for recurrence of febrile seizure in the intervention group ( P = 0.03). Conclusion: Oral serum iron supplementation does not significantly reduce the recurrence rate of febrile seizures in children aged 6–60 months. However, there is a trend toward reduction in the frequency of recurrence of febrile seizures, which is more pronounced in the subset with complex febrile seizures." @default.
• W4309463279 created "2022-11-28" @default.
• W4309463279 creator A5008296555 @default.
• W4309463279 creator A5013830001 @default.
• W4309463279 creator A5014203677 @default.
• W4309463279 creator A5021486215 @default.
• W4309463279 creator A5030812621 @default.
• W4309463279 creator A5031950502 @default.
• W4309463279 creator A5035675243 @default.
• W4309463279 creator A5049057294 @default.
• W4309463279 creator A5068911857 @default.
• W4309463279 date "2022-11-18" @default.
• W4309463279 modified "2023-09-30" @default.
• W4309463279 title "Effectiveness of prophylactic iron supplementation in the reduction of recurrence of febrile seizures in children: A prospective study with comparison with historical controls" @default.
• W4309463279 cites W138307089 @default.
• W4309463279 cites W1608634743 @default.
• W4309463279 cites W1790532227 @default.
• W4309463279 cites W1984224337 @default.
• W4309463279 cites W2054488887 @default.
• W4309463279 cites W2066006327 @default.
• W4309463279 cites W2077090586 @default.
• W4309463279 cites W2081932311 @default.
• W4309463279 cites W2124571377 @default.
• W4309463279 cites W2148180068 @default.
• W4309463279 cites W2423771561 @default.
• W4309463279 cites W2492490239 @default.
• W4309463279 cites W2558750425 @default.
• W4309463279 cites W2593444255 @default.
• W4309463279 cites W2754574848 @default.
• W4309463279 cites W2763613189 @default.
• W4309463279 cites W2883630143 @default.
• W4309463279 cites W2934266394 @default.
• W4309463279 cites W2967081414 @default.
• W4309463279 cites W2971644264 @default.
• W4309463279 cites W2982441356 @default.
• W4309463279 cites W2982846173 @default.
• W4309463279 cites W3146438850 @default.
• W4309463279 cites W3197505036 @default.
• W4309463279 cites W4200628487 @default.
• W4309463279 cites W4205133486 @default.
• W4309463279 cites W2906412332 @default.
• W4309463279 doi "https://doi.org/10.25259/jnrp-2022-7-19" @default.
• W4309463279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36743742" @default.
• W4309463279 hasPublicationYear "2022" @default.
• W4309463279 type Work @default.
• W4309463279 citedByCount "0" @default.
• W4309463279 crossrefType "journal-article" @default.
• W4309463279 hasAuthorship W4309463279A5008296555 @default.
• W4309463279 hasAuthorship W4309463279A5013830001 @default.
• W4309463279 hasAuthorship W4309463279A5014203677 @default.
• W4309463279 hasAuthorship W4309463279A5021486215 @default.
• W4309463279 hasAuthorship W4309463279A5030812621 @default.
• W4309463279 hasAuthorship W4309463279A5031950502 @default.
• W4309463279 hasAuthorship W4309463279A5035675243 @default.
• W4309463279 hasAuthorship W4309463279A5049057294 @default.
• W4309463279 hasAuthorship W4309463279A5068911857 @default.
• W4309463279 hasBestOaLocation W43094632791 @default.
• W4309463279 hasConcept C118552586 @default.
• W4309463279 hasConcept C120195587 @default.
• W4309463279 hasConcept C126322002 @default.
• W4309463279 hasConcept C168563851 @default.
• W4309463279 hasConcept C187212893 @default.
• W4309463279 hasConcept C188816634 @default.
• W4309463279 hasConcept C203092338 @default.
• W4309463279 hasConcept C2524010 @default.
• W4309463279 hasConcept C2778186239 @default.
• W4309463279 hasConcept C2780760677 @default.
• W4309463279 hasConcept C2987804222 @default.
• W4309463279 hasConcept C33923547 @default.
• W4309463279 hasConcept C44249647 @default.
• W4309463279 hasConcept C65409693 @default.
• W4309463279 hasConcept C67774102 @default.
• W4309463279 hasConcept C71924100 @default.
• W4309463279 hasConcept C82789193 @default.
• W4309463279 hasConceptScore W4309463279C118552586 @default.
• W4309463279 hasConceptScore W4309463279C120195587 @default.
• W4309463279 hasConceptScore W4309463279C126322002 @default.
• W4309463279 hasConceptScore W4309463279C168563851 @default.
• W4309463279 hasConceptScore W4309463279C187212893 @default.
• W4309463279 hasConceptScore W4309463279C188816634 @default.
• W4309463279 hasConceptScore W4309463279C203092338 @default.
• W4309463279 hasConceptScore W4309463279C2524010 @default.
• W4309463279 hasConceptScore W4309463279C2778186239 @default.
• W4309463279 hasConceptScore W4309463279C2780760677 @default.
• W4309463279 hasConceptScore W4309463279C2987804222 @default.
• W4309463279 hasConceptScore W4309463279C33923547 @default.
• W4309463279 hasConceptScore W4309463279C44249647 @default.
• W4309463279 hasConceptScore W4309463279C65409693 @default.
• W4309463279 hasConceptScore W4309463279C67774102 @default.
• W4309463279 hasConceptScore W4309463279C71924100 @default.
• W4309463279 hasConceptScore W4309463279C82789193 @default.
• W4309463279 hasLocation W43094632791 @default.
• W4309463279 hasLocation W43094632792 @default.
• W4309463279 hasLocation W43094632793 @default.
• W4309463279 hasOpenAccess W4309463279 @default.
• W4309463279 hasPrimaryLocation W43094632791 @default.
• W4309463279 hasRelatedWork W2005224329 @default.
• W4309463279 hasRelatedWork W2012498683 @default.

• next